Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/18660
Title: Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.
Author: Arena, U.
Vizzutti, F.
Abraldes, Juan G.
Corti, G.
Stasi, C.
Moscarella, S.
Milani, S.
Lorefice, E.
Petrarca, A.
Romanelli, R.G.
Laffi, G.
Bosch i Genover, Jaume
Marra, F.
Pinzani, M.
Keywords: Hepatitis C
Ecografia
Diagnòstic per la imatge
Fetge
Hepatitis C
Ultrasonic imaging
Diagnostic imaging
Liver
Issue Date: 2008
Publisher: BMJ Group
Abstract: Background: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in patients with chronic liver disease. Aim: To assess the value of TE for predicting the stage of fibrosis. Methods: Liver biopsy and TE were performed in 150 consecutive patients with chronic hepatitis C-related hepatitis (92 men and 58 women, age 50.6 (SD 12.5) years on the same day. Necro-inflammatory activity and the degree of steatosis at biopsy were also evaluated. Results: The areas under the curve for the prediction of significant fibrosis (⩾F2), advanced fibrosis (⩾F3) or cirrhosis were 0.91, 0.99 and 0.98, respectively. Calculation of multilevel likelihood ratios showed that values of TE <6 or ⩾12, <9 or ⩾12, and <12 or ⩾18, clearly indicated the absence or presence of significant fibrosis, advanced fibrosis, and cirrhosis, respectively. Intermediate values could not be reliably associated with the absence or presence of the target condition. The presence of inflammation significantly affected TE measurements in patients who did not have cirrhosis (p<0.0001), even after adjusting for the stage of fibrosis. Importantly, TE measurements were not influenced by the degree of steatosis. Conclusions: TE is more suitable for the identification of patients with advanced fibrosis than of those with cirrhosis or significant fibrosis. In patients in whom likelihood ratios are not optimal and do not provide a reliable indication of the disease stage, liver biopsy should be considered when clinically indicated. Necro-inflammatory activity, but not steatosis, strongly and independently influences TE measurement in patients who do not have cirrhosis.
Note: Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.2008.149708
It is part of: Gut, 2008, vol. 57, núm. 9, p. 1288-1293
Related resource: http://dx.doi.org/10.1136/gut.2008.149708
URI: http://hdl.handle.net/2445/18660
ISSN: 0017-5749
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
567042.pdf267.12 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.